Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US11077055 | DEXCEL PHARMA | Orally disintegrating compositions |
Apr, 2036
(12 years from now) |
Market Authorisation Date: 07 June, 2016
Treatment: NA
Dosage: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7396841 (Pediatric) | TAKEDA PHARMS NA | Injections |
Feb, 2022
(2 years ago) |
Market Authorisation Date: 27 May, 2004
Treatment: NA
Dosage: INJECTABLE;INTRAVENOUS